sivextro
merck sharp & dohme b.v. - tedizólíð fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
xydalba
abbvie deutschland gmbh & co. kg - dalbavancin hydrochloride - soft tissue infections; skin diseases, bacterial - sýklalyf fyrir almenn nota, - meðferð við bráðum húð og sýkingar í húð (absssi) hjá fullorðnum.
meropenem sun stungulyfs-/innrennslisstofn, lausn 1 g
sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 1 g
meropenem wh (meropenem w&h) stungulyfs-/innrennslisstofn, lausn 500 mg
williams & halls ehf. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg
cefabactin vet tafla 50 mg
le vet beheer b.v. - cefalexinum mónóhýdrat - tafla - 50 mg
cefabactin vet tafla 500 mg
le vet beheer b.v. - cefalexinum mónóhýdrat - tafla - 500 mg
clavubactin vet. (clavoral) tafla 250/62,5 mg
le vet b.v.* - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 250/62,5 mg
clavubactin vet. (clavoral) tafla 50/12,5 mg
le vet b.v.* - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 50/12,5 mg
spectrabactin vet tafla 200 mg/50 mg
dechra regulatory b.v. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 200 mg/50 mg
spectrabactin vet tafla 40 mg/10 mg
dechra regulatory b.v. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 40 mg/10 mg